GMP inspections are typically conducted on-site for pharmaceutical manufacturers. The outbreak of COVID-19 pandemic has brought about different approaches including off-site audits.

Learn from a Senior Officer of the Malaysian 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐠𝐞𝐧𝐜𝐲 (𝐍𝐏𝐑𝐀) on what is expected from regulators during a Remote Audit and Desktop Assessment From this webinar participants will gain an understanding of the following :-

✅ The challenges encountered by 𝐍𝐏𝐑𝐀 inspectors during GMP Inspection via Remote Audit or Desktop Assessment
✅ Industry best practices for a successful Remote Audit or Desktop Assessment
✅ Preparation expected by 𝐍𝐏𝐑𝐀 for a smooth Remote Audit or Desktop Assessment